IGF-1 and Bone Loss in Women With Anorexia Nervosa
Conditions: Anorexia Nervosa; Osteopenia; OsteoporosisInterventions: Drug: rhIGF-1; Drug: Risedronate; Drug: PlaceboSponsor: Massachusetts General HospitalRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2011 Category: Research Source Type: clinical trials
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
Conditions: Esophageal Cancer; Squamous Cell Carcinoma; AdenocarcinomaInterventions: Drug: Alendronate; Drug: Etidronate; Drug: Ibandronate; Drug: Risedronate; Drug: RaloxifeneSponsors: Merck Sharp & Dohme Corp.; World Health Information Science Consultants, LLCCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2010 Category: Research Source Type: clinical trials
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Condition: OsteoporosisInterventions: Drug: Teriparatide; Drug: Risedronate; Drug: Placebo; Dietary Supplement: Calcium; Dietary Supplement: Vitamin DSponsor: Eli Lilly and CompanyActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2009 Category: Research Source Type: clinical trials
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer
Conditions: Breast Cancer; Menopause; OsteopeniaInterventions: Drug: Risedronate; Drug: PlaceboSponsor: Hospices Civils de LyonCompleted - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2009 Category: Research Source Type: clinical trials
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer
Conditions: Breast Cancer; Menopause; OsteopeniaInterventions: Drug: Risedronate; Drug: PlaceboSponsors: Hospices Civils de Lyon; Hospices Civils de LyonActive, not recruiting - verified September 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2009 Category: Research Source Type: clinical trials
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer
Conditions: Breast Cancer; Menopause; OsteopeniaInterventions: Drug: Risedronate; Drug: PlaceboSponsor: Hospices Civils de LyonCompleted - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2009 Category: Research Source Type: clinical trials
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer
Conditions: Breast Cancer; Menopause; OsteopeniaInterventions: Drug: Risedronate; Drug: PlaceboSponsors: Hospices Civils de Lyon; Hospices Civils de LyonActive, not recruiting - verified September 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2009 Category: Research Source Type: clinical trials
